Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomi...
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
About this item
Full title
Author / Creator
Publisher
New York, NY: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study.
Because humoral immunity is believed to play a pivotal role in the pathogenesis of IgA nephropathy (IgAN), a prospective placebo-controlled randomized study was started in patients with IgAN using mycophenolate mofetil (MMF).
A total...
Alternative Titles
Full title
Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_755132327
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_755132327
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1111/j.1523-1755.2004.00588.x
